The aging population and those with amnestic mild cognitive impairment (aMCI) are at increased risk for developing Alzheimer's disease (AD). Individuals with aMCI in particular may display pathological changes in brain function that ultimately result in a diagnosis of AD. In this review, we focus specifically on hippocampal hyperexcitability, a pathology sometimes detectable years before diagnosis, which has been observed in individuals with aMCI. We describe how changes in hippocampal activity are associated with, or in some cases may be permissive for, the development of AD. Finally, we describe how lifestyle changes, including exercise and dietary changes, can attenuate cognitive decline and hippocampal hyperexcitability, potentially reducing the risk of developing AD.
memory. A deterioration in episodic memory (memory of autobiographical events), in some cases detectable as early as middle-age (Small, Stern, Tang, & Mayeux, 1999; Vandenbroucke & Dierckx, 1998) , may be indicative of the likelihood of developing mild cognitive impairment (MCI) and the debilitating and progressive neurodegenerative condition, Alzheimer's disease (AD; Small, Dixon, & McArdle, 2011) .
Generally, MCI consists of several characteristics that set this diagnosis apart from AD, leading some researchers to categorize the two disorders as completely separate entities (Albert et al., 2011) . Those with amnestic MCI (aMCI) in particular, which is specifically characterized by memory loss, often exhibit impairment of episodic memory in the absence of betaamyloid (A␤) plaques, tau tangles, and neuronal loss, all of which are hallmark characteristics observed in patients with AD (Albert et al., 2011) . However, because of the considerably accelerated rate at which these individuals progress to AD compared with healthy, age-matched individuals, aMCI has frequently been viewed as the prodromal stage of Alzheimer's disease (Mauri, Sinforiani, Zucchella, Cuzzoni, & Bono, 2012) . Cognitive tests assessing episodic memory are useful to both determine the extent of memory impairment in these patients and to identify individuals who are most likely to develop AD (Albert et al., 2011; Petersen, 2004) . We find it interesting that, in the years preceding AD diagnosis, individuals with aMCI often exhibit excess activation (hyperexcitability) in brain regions responsible for memory, including the hippocampus. This excess activation is often measured using a high-resolution functional magnetic resonance imaging (fMRI) scan while the individual performs a memory task and is correlated to the degree of memory impairment in diagnostic tests for presence of aMCI, and later, the likelihood to develop AD (Bakker et al., 2012) . However, it is important to note that excess hippocampal activation cannot yet be considered a biomarker of AD development. Nevertheless, understanding the relationship between the hippocampal hyperactivity exhibited in individuals diagnosed with aMCI and the correlation to development of AD is crucial. In this section, we highlight how age-related changes in the hippocampus can result in hyperexcitability leading to cognitive impairment and the potential development of AD.
Hippocampal Hyperexcitability
As individuals age, prominent deficits in spatial learning, working memory, and episodic memory can be observed (Gallagher & Rapp, 1997) . These specific types of memory-related deficits have a common neurobiological source, the hippocampus (Wilson, Gallagher, Eichenbaum, & Tanila, 2006) . In the years prior to AD diagnosis, hyperactivity or excess activation of the memory network, comprised of the hippocampus, medial temporal lobe, and several cortical regions, is detectable (Sperling et al., 2010) . Hippocampal hyperactivity has been observed in numerous studies examining individuals at genetic or familial risk of AD (Bondi, Houston, Eyler, & Brown, 2005; Quiroz et al., 2010) , as well as asymptomatic and minimally impaired older individuals with A␤ deposition (Sperling et al., 2010) . In longitudinal studies, the degree of hippocampal overactivation has been correlated with declines in memory (Bookheimer et al., 2000) .
For many years, this hyperactivity was thought to be a compensatory response for deteriorating neuronal circuitry, such that greater cognitive effort was needed to achieve comparable (or less than comparable) performance (Bondi et al., 2005) , but more recent evidence suggests that hyperactivity of the memory network may signify neuronal excitotoxicity, a pathological process in which neurons are killed due to overactivation, and could be permissive for the development of AD, making it a potential therapeutic target. With age-associated memory deficits, as seen in aMCI, the hippocampal neurons are usually intact with little to no detectable neuron loss Rapp & Gallagher, 1996) . Rather, there are age-related alterations in the functional connections of the cell groups that comprise the hippocampus, and these changes may be permissive for the development of AD.
The hippocampus is comprised of three distinct subregions: the dentate gyrus (DG), cornu ammonis 3 (CA3), and cornu ammonis 1 (CA1). Flow from Layer 2 of the entorhinal cortex (EC) enters the DG through what is termed the perforant pathway, which projects to the CA3 through the mossy fiber pathway. Neurons in the CA3 then connect to the CA1 via the Schaffer-collateral pathway. Each of these subregions has specific characteristics that distinguish them from one another. With increasing age, hyperxcitability exhibited in these subregions affects learning and memory in different ways (Ji & Maren, 2008) .
Loss in synaptic strength in the DG has been observed in both aMCI patients and aged animals with memory impairment. Aged rats exhibiting memory deficits have approximately a fourth to a third fewer synaptic connections from the EC to the DG along the perforant pathway (Geinisman, deToledo-Morrell, Morrell, Persina, & Rossi, 1992; Smith, Adams, Gallagher, Morrison, & Rapp, 2000) . The greater the loss of these synaptic connections, the more severe the memory deficits observed (Smith et al., 2000) . Though the loss of inputs from the EC is associated with less excitation in the DG of aged rats exhibiting memory impairments (Barnes & McNaughton, 1980) , the individual synapses are actually more powerful because of an increase in quantal size, defined as the synaptic response to the release of a neurotransmitter from a single vesicle (Foster, Barnes, Rao, & McNaughton, 1991) . Patients with aMCI also have fewer synapses in the DG than age-matched controls without memory impairment (Scheff, Price, Schmitt, & Mufson, 2006) . Furthermore, older individuals with memory impairment exhibit atrophy of the perforant pathway between the EC and the DG (Kalus et al., 2006) .
Conversely, the firing rates of CA3 cells are actually increased in aged, memory-impaired rats (Wilson, Ikonen, Gallagher, Eichenbaum, & Tanila, 2005) . This hyperexcitability of the CA3 may be a result of the diminished input from the EC to the CA3 (Barnes & McNaughton, 1980; Geinisman et al., 1992; Smith et al., 2000) , without a commensurate loss of the excitatory recurrent synapses in the CA3 (Rapp & Gallagher, 1996; Rapp, Stack, & Gallagher, 1999; Smith et al., 2000) . Findings of age-related CA3 hyperexcitability are not limited to rodents. Studies using fMRI technology showcase greater hippocampal activation, as indicated by increased blood-oxygen-leveldependent (BOLD) activation along the DG-CA3 pathway in aged individuals with poor memory performance, as well as aMCI patients (Dickerson et al., 2004; Sperling, 2007) , and this activation is predictive of both the degree and rate of conversion to AD (Miller et al., 2008) .
The last region discussed, the CA1, is perhaps the most studied of all the hippocampal subregions in rodents. CA1-related memory deficits observed in aged, memory-impaired rats are not associated with a loss of synapses from CA3 or EC input Smith et al., 2000) , rather, they are believed to result from an increase in the number of silent synapses (or synapses without excitatory glutamatergic ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMPA receptors) and calcium channels, which result in long-lasting excitation signals. (Nicholson, Yoshida, Berry, Gallagher, & Geinisman, 2004; Thibault & Landfield, 1996) . The latter is thought to explain why CA1 neurons are highly sensitive to excitotoxicity and more susceptible to loss in AD (West, Kawas, Martin, & Troncoso, 2000) . Though the alterations described are relatively subtle compared with the robust alterations in neuronal functioning observed in AD, these changes in neural network activity may serve not only as a future biomarker for AD, but also could be permissive for the development of AD, by propagating pathologies exhibited during the disease progression.
Animal studies have demonstrated that increases in neural activity increase processing of the amyloid precursor protein (APP), leading to increased production of A␤, a hallmark of AD (Kamenetz et al., 2003) . Thus, the age-related increase in CA3 activity observed in aged, memory-impaired rats and aMCI patients (Bakker et al., 2012; Yassa et al., 2010) could increase A␤ production and deposition, eventually leading to the formation of A␤ plaques. Additional support comes from mouse models of AD in which A␤ plaques are found specifically within the vicinity of hyperactive neurons (Busche et al., 2008) . The role of hyperactivity in mediating A␤ levels has recently been confirmed in studies using chemogenetic modulation of neural activity to either decrease or increase neuronal activity, leading to markedly decreased or increased A␤ aggregation and deposition, respectively (Yuan & Grutzendler, 2016) . Furthermore, circumstantial evidence from patients with temporal lobe epilepsy exhibiting elevated neuronal activity show that amyloid plaques develop as early as 30 years of age (Mackenzie & Miller, 1994) , suggesting that increased activity resulting from epilepsy may drive A␤ production and deposition.
The effect of hyperactivity is not limited to A␤. Tau propagation and pathology, the second hallmark of AD, is also enhanced by neural activity (Wu et al., 2016) . Increased neuronal activity promotes trans-synaptic spread of tau pathology, in which tau can be released into the extracellular space independently of cell death (Chai, Dage, & Citron, 2012) and compromise the functionality of tau within a neighboring healthy neuron, thereby inducing further tau aggregation (Clavaguera et al., 2009 ). In addition, in tau -/-mice, an animal model in which tau has been genetically removed, seizure susceptibility and cognitive impairment are attenuated, suggesting that the relationship between tau pathology and hyperactivity is likely cyclical. Indeed, in mouse and Drosophila genetic models of epilepsy, characterized by excess neuronal activation, tau removal dampens the hyperexcitability observed by reducing seizure-related mortalities (Holth et al., 2013) . Thus, reduction in tau levels and hyperexcitability represent viable therapeutic targets for AD currently being pursued (Himmelstein, Ward, Lancia, Patterson, & Binder, 2012; Holth et al., 2013) .
The network dysfunction observed in those at risk for AD may also explain the prevalence of epilepsy in AD patients. For example, increased incidence of seizures is highest among those with early-onset dementia and remains increased compared with the general population as these individuals progress to severe dementia (Cloyd et al., 2006) . Pharmaceuticals that attenuate this excess activation, such as the antiepileptic drug levetiracetem, can dose-dependently improve memory in aged rats (Koh, Haberman, Foti, McCown, & Gallagher, 2010) and reduce both hippocampal hyperactivity and memory impairments in patients with aMCI, as indicated by decreased BOLD activation (Bakker et al., 2012) . Together, these studies suggest that increased hippocampal activation is not merely a compensatory response, but a dysfunctional condition, and a condition that may be permissive for the development of AD. Below, we discuss lifestyle changes that may attenuate this hippocampal hyperexcitability, thereby reducing the risk of developing AD.
Lifestyle Factors That Influence the Risk for Alzheimer's Disease
With aging comes a normal decline in cognition, as well as increased susceptibility to developing fatal diseases, such as AD. Whereas the cause of age-related decline may be selfevident (decrease in brain volume, slowing of neurogenesis, loss of synapses, etc.), the mechanisms underlying AD are more complex and may result from numerous machinations that are not well-understood. However, because these age-related changes in brain function are so detrimental, and in some cases deadly, much research has focused on potential preventive measures that can be taken to slow the progression from excess neuronal activation to cognitive decline or prevent development altogether. These measures include, but are not limited to, exercise and dietary changes. Below we summarize the ways in which changes in exercise habits and dietary choices may prevent or slow cognitive decline through a common mechanism, an increase in brain-derived neurotrophic factor (BDNF), a protein responsible for maintaining neuronal growth and survival.
Exercise
Aerobic exercise has many benefits for the aging population, including improved performance on cognitively demanding tasks, as well as reduced risk of neurodegenerative conditions, such as Alzheimer's and Parkinson's diseases (Kalaria et al., 2008) . The mechanisms by which exercise can serve as a cognitive enhancer have been of interest in the literature. Exercise training aids in the growth of neurons in aged rodents exposed to voluntary wheelrunning, an effect associated with an increase in BDNF levels (Littlefield, Setti, Priester, & Kohman, 2015) . In addition, BDNF may play a major role in the reduction of hyperexcitability potentially by preventing glutamate release from the presynaptic neuron while selectively enhancing the firing of postsynaptic glutamate receptors, which promote learning and memory (Kang & Schuman, 1995) . Reduction of this neuronal activity is also important for the prevention of seizures, which are more prevalent in AD patients compared with age-matched individuals without memory deficits (Cloyd et al., 2006) . Although exercise can also protect against seizure susceptibility (Epps et al., 2013) , the mechanisms are unclear. However, there is evidence to suggest that galanin, a peptide involved in a variety of physiological and behavioral functions, acts as an anticonvulsant after aerobic exercise. Rats that undergo chronic wheel-running exhibit increased latency to induced motor seizures, which is associated with an increase in galanin messenger RNA (mRNA; Epps et al., 2013) . Reducing seizure susceptibility through exercise is important, even if seizures are eventually found to be an epiphenomenon rather than directly linked to pathogenesis of AD, because cognitive deterioration is greater after seizure onset (Yamaguchi et al., 1997) .
Diet
In addition to exercise, dietary changes, including consumption of omega-3 fatty acids and caloric restriction (CR), are also associated with reduced hippocampal hyperactivity, increased brain volume, and improvement cognitive performance on spatial memory tasks (Bauer et al., 2014) . Omega-3 fatty acids, which are important for maintaining cell membranes and normal brain function, and curcumin, an anti-inflammatory molecule, elevate levels of molecules important for synaptic plasticity, including BDNF (Gomez-Pinilla, 2011) . In addition, diets of oilrich fish and certain nuts and seeds, which contain high levels of the beneficial omega-3 polyunsaturated fatty acid, docosahexaenoic acid (DHA), can elevate levels of BDNF and enhance cognitive function in rodents (Wu, Ying, & Gomez-Pinilla, 2004) .
Caloric restriction, or reducing the amount of calories consumed, enhances synaptic plasticity by increasing BDNF levels (Lee, Seroogy, & Mattson, 2002) . CR can also reduce hippocampal damage after seizure (Duan, Lee, Guo, & Mattson, 2001) , attenuate AD-related pathology and behavioral deficits in AD mouse models (Lu et al., 2016) , and improve memory in the elderly (Mogi et al., 1994; Correction to Witte et al., 2009 ). These results suggest that BDNFsignaling pathways can be neuroprotective, potentially by reducing neuronal hyperactivity. Other dietary changes, such as the ketogenic diet, can also protect against cognitive decline in aging. For example, a ketogenic diet, consisting of high fat and low carbohydrate content, can protect against seizures by reducing neuronal excitability (Likhodii et al., 2003; Neal et al., 2009) and is sometimes prescribed by a physician for individuals with epilepsy. This protective effect may be because ketone bodies (water-soluble molecules produced by the liver that result from low carbohydrate intake or fasting) are released. Ketone bodies may protect against excessive neuronal excitability, as seen in seizures, by blocking the release of glutamate into the extracellular space (Juge et al., 2010) . This is important because increases in extracellular glutamate are associated with memory impairment in rodents (Hunsberger, Rudy, Batten, Gerhardt, & Reed, 2015; Hunsberger, Weitzner et al., 2015) and has been linked to aging (Stephens et al., 2014) and AD (Butterfield & Pocernich, 2003) .
Conclusion
Though there are many risk factors for AD, hyperexcitability is one that occurs early in the disease process and in some cases is detectable in patients with aMCI. In addition, hyperactivity of the hippocampal network may be predictive of an AD diagnosis and the rate of decline (Miller et al., 2008) . Although there is potential for hyperexcitability to serve as a future biomarker for AD, there is still need for additional clinical studies to examine the progression and connections of this excess firing to AD development. In addition, in future directions, researchers should aim to better understand the mechanisms underlying the lifestyle changes that reduce hyperexcitability. In this review, we discussed studies that have examined possible ways in which lifestyle changes such as diet and physical activity can protect against hippocampal hyperactivity. Specifically, aerobic exercise and diet modification potentially reduce the risk for hyperexcitability by (a) preventing the release of glutamate from presynaptic neurons, (b) increasing galanin, which is protective against seizures, (c) balancing BDNF levels, which in turn promotes cell growth, and (d) increasing levels of ketone bodies, which block the release of glutamate. As a decline in glutamate transporters, and thereby increased extracellular glutamate, may be permissive for cognitive decline and the spread of AD-related pathology, interventions aimed at reducing or preventing these changes could promote healthy cognitive aging. In addition, promotion of cellular growth via increased levels of BDNF is protective against neuronal loss, one of the key hallmarks of AD. In summary, implementation of dietary changes and an aerobic exercise regimen are two attainable lifestyle changes that may prevent or delay the progression from healthy aging to aMCI and AD.
